CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 29 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $117,000 | -8.6% | 67,554 | +2.6% | 0.00% | – |
Q3 2016 | $128,000 | +11.3% | 65,846 | -0.3% | 0.00% | – |
Q2 2016 | $115,000 | +69.1% | 66,072 | +32.1% | 0.00% | – |
Q1 2016 | $68,000 | -25.3% | 50,011 | -7.3% | 0.00% | – |
Q4 2015 | $91,000 | -9.9% | 53,975 | +3.8% | 0.00% | – |
Q3 2015 | $101,000 | -1.0% | 52,014 | +37.5% | 0.00% | – |
Q2 2015 | $102,000 | – | 37,834 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |